Special viruses that can disable a fundamental defence system used by bacteria are opening a new front in the war against superbugs.
Penicillin and other antibiotics are among the most important medical breakthroughs of all time, saving hundreds of millions of lives.
But over the years, bacteria have evolved clever new ways to protect themselves from antibiotics, resulting in the emergence of powerful drug-resistant superbugs which kill 25 000 people every year in Europe.
While some researchers are working on new antibiotics, others are taking a different approach: using viruses known as bacteriophages that specifically target bacteria without damaging human cells.
Normally, bacteria steal part of the bacteriophage’s DNA and add it to their own, teaching them to recognise it as a threat.
It’s a technique that has inspired CRISPR-Cas technology, where researchers have learnt from bacteria how to edit genomes with unprecedented ease.
Now scientists are creating bacteriophages that can disable the CRISPR-Cas system in bacteria, removing this essential failsafe.
‘It can be a very simple and cheap process.’
Dr Stan JJ Brouns, Delft University of Technology, the Netherlands
‘We are looking at how we can knock out the so-called CRISPR-Cas system that provides bacteria with a natural immune response,’ said Dr Stan JJ Brouns at Delft University of Technology in the Netherlands.
Some bacteriophages have been found to have proteins that naturally inhibit CRISPR systems. If the genetic code for these proteins can be transplanted into other bacteriophages, doctors would have a potent weapon against antimicrobial-resistant bacteria.
As part of the EU-funded REMEMBER project, Dr Brouns and his team are looking for bacteriophages with the ability to evade CRISPR so that they could copy and paste chunks of their DNA into other bacteriophages to create an arsenal of phage therapies.
There are, however, a few hurdles to clear before this research makes it into hospital treatment rooms. For one thing, bacteriophages can be tricky to work with and they may struggle to secure approval from health authorities.
‘Chemicals behave in consistent and predictable ways whereas bacteriophages are always mutating,’ said Dr Brouns. ‘We may need to start thinking now about specific rules for regulating phage therapy.’
While developing new phage therapies is a labour-intensive task, one of the upsides is that producing phage therapies should be inexpensive. ‘It can be a very simple and cheap process,’ said Dr Brouns. ‘In principle you need to infect some cells with phages and the cells will make lots more phages – like small but efficient phage factories.’
If you liked this article, please consider sharing it on social media.
The power of the CRISPR-Cas system has been neatly illustrated by scientists studying how bacteria and viruses evolve together. Evolution is often thought of as a slow process but in microbes, a new generation comes along every 20 minutes.
This means researchers can expose bacteria to bacteriophages and watch as they do battle. Dr Edze Westra at Exeter University, UK, has found that bacteria with the CRISPR-Cas system can drive a bacteriophage to extinction within a few days.
‘When exposed to a potentially lethal phage, bacteria respond strongly by favouring their CRISPR-Cas system,’ said Dr Westra, who is examing the issue as part of the EU-funded PROTECT project. ‘But if we knock out CRISPR-Cas they rely on different defence mechanisms which are less effective against phages. This has a massive influence on their ability to thrive in their environment.’
For more information: cordis.europa.eu/project/rcn/108628_en.html
The rise of alternative health practices and a quest for purity can partly explain the falling confidence in vaccines which is driving outbreaks of preventable diseases such as measles, according to Heidi Larson, professor of anthropology, risk and decision medicine at the UK’s London School of Hygiene & Tropical Medicine. She is working to understand the causes of vaccine hesitancy in order to devise ways of rebuilding trust.
Some materials are special not for what they contain, but for what they don’t contain. Such is the case with metal-organic frameworks (MOFs) – ultra-porous structures that are being developed for a variety of future applications from fire-proofing to drug-delivery.
Artificial intelligence (AI) and cyber security should be priorities in future EU industrial research policy in order to reinvigorate industry and recover jobs that have been lost abroad, according to Professor Jürgen Rüttgers, a former research minister in Germany.
Tiny pieces of plastic, now ubiquitous in the marine environment, have long been a cause of concern for their ability to absorb toxic substances and potentially penetrate the food chain. Now scientists are beginning to understand the level of threat posed to life, by gauging the extent of marine accumulation and tracking the movement of these contaminants.
Understanding people’s fears is the key to increasing confidence.
Are metal organic frameworks the hole-y grail of nanomaterials?
A new report on how to reinvigorate Europe's industrial sector recommends prioritising AI and cyber security research.